Nobel Award Honors Pioneering Body's Defenses Discoveries

The Nobel Prize in Physiology or Medicine has been awarded for transformative discoveries that illuminate how the immune system attacks dangerous infections while sparing the healthy tissues.

Three renowned scientists—Japan's Prof. Sakaguchi and US scientists Mary Brunkow and Fred Ramsdell—received this honor.

Their research uncovered unique "security guards" within the defense system that remove rogue immune cells capable of harming the body.

These discoveries are now enabling new therapies for immune disorders and cancer.

The winners will share a prize fund valued at 11 million Swedish kronor.

Crucial Findings

"The research has been essential for comprehending how the immune system operates and the reason we do not all suffer from serious autoimmune diseases," stated the chair of the Nobel Committee.

The team's research explain a fundamental question: How does the immune system protect us from numerous infections while keeping our healthy cells intact?

The immune system employs immune cells that scan for indicators of disease, even viruses and germs it has never encountered.

Such cells utilize detectors—called recognition units—that are generated randomly in countless variations.

That gives the defense network the ability to combat a broad range of invaders, but the randomness of the process unavoidably produces immune cells that may target the body.

Security Guards of the Body

Researchers previously understood that some of these harmful white blood cells were destroyed in the thymus—where immune cells develop.

The latest Nobel Prize recognizes the identification of T-reg cells—described as the body's "security guards"—which patrol the system to neutralize any defenders that attack the body's own tissues.

We know that this process fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee added, "The findings have laid the foundation for a novel area of investigation and accelerated the development of innovative therapies, for example for tumors and immune disorders."

In malignancies, regulatory T-cells prevent the system from attacking the tumor, so studies are focused on reducing their quantity.

In autoimmune diseases, experiments are testing boosting regulatory T-cells so the organism is not under attack. A comparable approach could also be useful in minimizing the risks of organ transplant failure.

Pioneering Experiments

Professor Shimon Sakaguchi, of a Japanese institution, conducted tests on rodents that had their thymus extracted, leading to self-attack conditions.

He demonstrated that introducing defense cells from other animals could prevent the illness—implying there was a mechanism for preventing immune cells from harming the host.

Mary Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Dr. Ramsdell, currently at a biotech firm in a California city, were studying an inherited immune disorder in rodents and humans that resulted in the discovery of a gene vital for the way regulatory T-cells operate.

"The pioneering work has uncovered how the body's defenses is kept in check by T-reg cells, stopping it from accidentally targeting the body's own tissues," said a prominent biological science specialist.

"The work is a striking illustration of how fundamental physiological research can have broad implications for public health."